PD52-06 CLINICAL PREDICTORS AND SURVIVAL OUTCOME OF PATIENT RECEIVING SUBOPTIMAL NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER: A SINGLE-CENTER EXPERIENCE